厌氧菌
抗生素耐药性
重症监护医学
抗菌剂
无氧运动
微生物学
人口
抗药性
临床微生物学
医学
经验性治疗
生物
抗生素
细菌
环境卫生
生理学
遗传学
作者
Anshul Sood,Pallab Ray,Archana Angrup
出处
期刊:Anaerobe
[Elsevier BV]
日期:2022-04-10
卷期号:75: 102559-102559
被引量:15
标识
DOI:10.1016/j.anaerobe.2022.102559
摘要
To date, antimicrobial susceptibility testing (AST) in anaerobes is highly disarrayed. The testing is not routinely performed in many laboratories to direct appropriate antimicrobial therapy, and literature on AST remains scarce. This review aims to present the current methods employed for the AST of anaerobic bacteria both in routine and research. Anaerobes are potential human pathogens and predominate the human microbiota. Despite their significant role in human health and disease, they are not paid enough heed. The educated experience-based treatment has often been instituted with anaerobic infections due to the challenging AST and relatively predictable patterns of antimicrobial resistance (AMR). However, the AMR in anaerobes remains no more predictable, especially in Gram-negative anaerobes like Bacteroides spp., where multi-drug resistance is also emerging. The changing antibiograms and the emergence of resistance determinants in anaerobes necessitate routine AST, periodic monitoring, and literature review of these organisms. The present scenario dictates to limit the empirical management of anaerobic infections and encourage consistent AST practice in routine by employing economical, faster, and more pragmatic approaches, especially in tertiary care setups that cater to a vast patient population and are held accountable for producing accurate clinical and surveillance data. The article may provide a broad perspective on the topic and different AST solutions.
科研通智能强力驱动
Strongly Powered by AbleSci AI